Mineralys CCO sells 7,438 shares after option exercise
Rhea-AI Filing Summary
Mineralys Therapeutics, Inc. (MLYS) reported that Chief Commercial Officer Warren Eric exercised stock options for 7,438 shares of common stock on September 21, 2026 at an exercise price of $13.24 per share and sold the same 7,438 shares at a weighted-average price of $28.1172 per share. These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026. Following the option exercise, Eric held 230,563 stock options directly, expiring on April 21, 2035, subject to the stated vesting schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 7,438 shares ($111K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Warren Eric
Role
Chief Commercial Officer
Sold
7,438 shs ($209K)
Approx. gross sale proceeds
$209K
Approx. exercise cost
$98K
Approx. pre-tax spread
$111K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F3 | 7,438 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 7,438 | $13.24 | $98K |
| Sale | Common Stock F1, F2 | 7,438 | $28.1172 | $209K |
Holdings After Transaction:
Stock Option — 230,563 contracts (Direct);
Common Stock — 38,400 shares (Direct)
Footnotes (3)
- F1. These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026.
- F2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.21. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- F3. The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
Key Figures
Shares sold: 7,438 shares
Weighted-average sale price: $28.1172 per share
Option exercise price: $13.24 per share
+5 more
8 metrics
Shares sold
7,438 shares
Common stock sold by Warren Eric on September 21, 2026
Weighted-average sale price
$28.1172 per share
Sale of 7,438 shares of common stock; individual prices $27.94–$28.21
Option exercise price
$13.24 per share
Exercise of stock option for 7,438 underlying shares of common stock
Options exercised
7,438 options
Stock options converted into 7,438 shares of common stock on September 21, 2026
Remaining stock options
230,563 options
Stock options held directly by Warren Eric following the reported transactions
Option expiration date
April 21, 2035
Expiration of the stock option that was partially exercised
Rule 10b5-1 plan adoption date
March 27, 2026
Date the stock selling plan governing these transactions was adopted
Sale price range
$27.94–$28.21 per share
Range of prices for the multiple transactions included in the weighted-average sale
Key Terms
Rule 10b5-1 stock selling plan, weighted-average price, stock option, underlying shares
4 terms
Rule 10b5-1 stock selling plan regulatory
"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan"
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
stock option financial
"The stock option vested as to 25% of the underlying shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Mineralys Therapeutics (MLYS) disclose about Warren Eric’s recent Form 4 transactions?
The company reported that Chief Commercial Officer Warren Eric exercised options for 7,438 shares of common stock at $13.24 per share and sold the same 7,438 shares at a weighted-average price of $28.1172 per share on September 21, 2026.
Were Warren Eric’s MLYS trades made under a Rule 10b5-1 trading plan?
Yes. The Form 4 states that the reported transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026, indicating they were pre-arranged under that plan.
What was the exercise price and type of security for Warren Eric’s Mineralys options?
He exercised a stock option covering 7,438 underlying shares of Mineralys common stock at an exercise price of $13.24 per share. The option expires on April 21, 2035, with vesting over time per the disclosed schedule.
How many Mineralys Therapeutics stock options does Warren Eric hold after these transactions?
After the reported option exercise, Warren Eric held 230,563 stock options directly, as reported in the Form 4, representing his remaining derivative position from this grant.
What is the vesting schedule for Warren Eric’s Mineralys stock option mentioned in the Form 4?
The filing states the stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.
